SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Clinical and Applied Thrombosis/Hemostasis
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1076029607303965v1
14/1/99    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Wiwanitkit, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiwanitkit, V.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Correlation Between Thrombomodulin and Severe Preeclampsia: A Summary

Viroj Wiwanitkit, MD

Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, wviroj{at}yahoo.com

Thrombomodulin is a critical cofactor in the initiation of the protein C anticoagulant pathway. Plasma levels of thrombomodulin are regulated on a genetic basis, but more important is the dependence on a series of other atherosclerotic risk factors, such as hypertriglyceridemia, stroke, cancer, and diabetes. There is considerable controversy regarding the clinical role of thrombomodulin level as a risk factor of severe preeclampsia. A retrospective analysis of recent reports on the thrombomodulin level and its correlation to preeclampsia was performed to assess the correlation between the pattern of thrombomodulin level and preeclampsia. From the available 4 case-control studies, 149 patients and 120 controls are evaluated. The overall average thrombomodulin level for the patients and controls is 66.7 ± 11.9 ng/mL and 45.7 ± 7.3 ng/mL, respectively, which is significantly higher in patients than in controls (P < .05). In addition, the author reports a significant correlation between population ethnicity and thrombomodulin level (r = .96; P < .05).

Key Words: thrombomodulin • severe preeclampsia

This version was published on January 1, 2008

Clinical and Applied Thrombosis/Hemostasis, Vol. 14, No. 1, 99-101 (2008)
DOI: 10.1177/1076029607303965
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 CLIN APPL THROMB HEMOSTHome page
F. G. Varol, L. Ozgen, N. C. Sayin, and M. Demir
Correlation Between Maternal Plasma Thrombomodulin and Infant Birth Weight in Hypertensive Disorders of Pregnancy
Clinical and Applied Thrombosis/Hemostasis, April 1, 2009; 15(2): 166 - 170.
[Abstract] [PDF]


Advertisement